Publication | Open Access

The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway

InflammationPi3k/akt/smad PathwayHepatologyBiliary TractMedicineLiver PhysiologyPathologyCell DeathHepatotoxicityLiver DiseaseHepatology FibrosisPharmacologyCell BiologyCell SignalingDrug-induced Liver InjuryOxidative StressAnti-fibrotic Effects